Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease
Chronic heart failure is debilitating, often fatal, expensive to treat and common. In most
patients it is a late consequence of myocardial infarction (MI). The intracellular signals …
patients it is a late consequence of myocardial infarction (MI). The intracellular signals …
Role of p38 inhibition in cardiac ischemia/reperfusion injury
S Kumphune, S Chattipakorn… - European journal of clinical …, 2012 - Springer
The p38 mitogen-activated protein kinases (p38s) are Ser/Thr kinases that are activated as a
result of cellular stresses and various pathological conditions, including myocardial …
result of cellular stresses and various pathological conditions, including myocardial …
The case for inhibiting p38 mitogen-activated protein kinase in heart failure
P Arabacilar, M Marber - Frontiers in Pharmacology, 2015 - frontiersin.org
This minireview discusses the evidence that the inhibition of p38 mitogen-activated protein
kinases (p38 MAPKs) maybe of therapeutic value in heart failure. Most previous …
kinases (p38 MAPKs) maybe of therapeutic value in heart failure. Most previous …
New therapeutic targets in cardiology: p38 alpha mitogen-activated protein kinase for ischemic heart disease
ED Martin, GF De Nicola, MS Marber - Circulation, 2012 - Am Heart Assoc
Phosphorylation is the process through which extracellular signals are communicated to the
interior of the cell and it is catalyzed by kinases. The protein kinases transfer the terminal …
interior of the cell and it is catalyzed by kinases. The protein kinases transfer the terminal …
p38 mitogen-activated protein kinase inhibitors for the treatment of chronic cardiovascular disease.
TM Behr, M Berova, CP Doe, H Ju… - Current Opinion in …, 2003 - europepmc.org
p38 Mitogen-activated protein kinase (MAPK) has been implicated in cardiovascular
disease and is activated by various factors, including neurohormones (eg, catecholamines …
disease and is activated by various factors, including neurohormones (eg, catecholamines …
Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease
M Fisk, PR Gajendragadkar, KM Mäki-Petäjä… - American Journal of …, 2014 - Springer
Abstract p38 mitogen-activated protein kinases (p38 MAPKs) are key signalling molecules
that regulate cellular behavior in response to environmental stresses. They regulate pro …
that regulate cellular behavior in response to environmental stresses. They regulate pro …
p38 MAPK pathway in the heart: new insights in health and disease
R Romero-Becerra, AM Santamans… - International Journal of …, 2020 - mdpi.com
The p38 mitogen-activated kinase (MAPK) family controls cell adaptation to stress stimuli.
p38 function has been studied in depth in relation to cardiac development and function. The …
p38 function has been studied in depth in relation to cardiac development and function. The …
The p38 mitogen-activated protein kinase pathway—a potential target for intervention in infarction, hypertrophy, and heart failure
The p38 mitogen-activated protein kinases (p38s) are stress-activated Ser/Thr kinases. Their
activation has been associated with various pathological stressors in the heart. Activated …
activation has been associated with various pathological stressors in the heart. Activated …
Targeting p38-MAPK in the ischaemic heart: kill or cure?
The p38-MAPK pathway plays an important role in myocardial ischaemia/reperfusion injury
and has been implicated in the regulation of cardiac gene expression, myocyte hypertrophy …
and has been implicated in the regulation of cardiac gene expression, myocyte hypertrophy …
p38 MAP kinases in the heart
T Yokota, Y Wang - Gene, 2016 - Elsevier
Abstract p38 kinases are members of the mitogen-activated protein kinases (MAPK) with
established contribution to a wide range of signaling pathways and different biological …
established contribution to a wide range of signaling pathways and different biological …